56 results
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
P.O. BOX 8016, CARY, NC 27512
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
ALIGOS THERAPEUTICS, INC
SC TO-I
EX-99
3q449bjsfo1l6pxwpv
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
pp59dv1iucqo t6
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
eio7s
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
guk3hreq hyz5e
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
nzxsq0ecb29mdh7aw
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
95i6j zsbo
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
loxg86hihiv4zw
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
pkt9eo zd3gu
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-C
0albo69 ptwq02
25 Jan 24
Information about tender offer
6:12am
8-K
z5fw5bkq
25 Jan 24
Other Events
6:06am
8-K
EX-99.1
r397fmhh
25 Jan 24
Other Events
6:06am
D
vss67buv
7 Nov 23
$92.15 mm in equity / options / securities to be acquired, sold $92.15 mm, 11 investors
12:03pm
8-K
EX-10.1
cvhq x0c9w7mt9ujdsk
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm